13-05-2025 20:41 via medpagetoday.com

HIV Drugs and Alzheimer's; Duchenne Drug Shows Benefit; PFAS and Cognitive Changes

(MedPage Today) -- Nucleoside reverse transcriptase inhibitors--antiretroviral drugs approved to treat HIV and hepatitis B--were associated with a lower incidence of Alzheimer's disease in two large insurance databases. (Alzheimer's &amp...
Read more »

Medical news



Sedentary Time Tied to Brain Volume, Worse Cognition in Older Adults
Expect More Downside Risk in Medicare's Payment Models, CMS Official Says
Better Survival in BRCA-Mutated Breast Cancer With Neoadjuvant Olaparib-Chemo Combo
Doctors, Other Healthcare Workers Strike in Washington State
Low LDL and Bleeding Risk; Improved HoFH Life Expectancy; ANGPTL4 mAb Progress
CVS Drops Obesity Drug; Once-Weekly Growth Hormone; WeightWatchers' Bankruptcy
FDA, RFK Jr. Aim to Remove Ingestible Fluoride Products Used to Protect Kids' Teeth
Would You Recognize the Signs of Trafficking in a Patient?
Late Abortions Are Rare. The U.S. Just Lost a Clinic That Performed Them Since 1973.
Polarized and Politicized: Can We Find Middle Ground in Youth Gender Care?
Global Progress Continues on Reducing Rotavirus Burden, With Caveats
USPSTF Reaffirms Universal Syphilis Screening in Pregnancy
Pfizer Confirms: Leading JAK Inhibitor Often Comes With Weight Gain
Biden's Prostate Nodule; RFK Jr. Swims in Sewage-Tainted Creek; Stockpiling Drugs
Desktop versie